Literature DB >> 31293016

Preparation of hybrid porcine thymus containing non-human primate thymic epithelial cells in miniature swine.

Mitsuhiro Sekijima1, Hisashi Sahara1,2, Akira Shimizu3, Takehiro Iwanaga1, Takahiro Murokawa1, Yuichi Ariyoshi1, Thomas Pomposelli2, Mohsen Khosravi Maharlooei2, Megan Sykes2, Kazuhiko Yamada2.   

Abstract

BACKGROUND: We have achieved greater than a 6-month survival of a life-supporting kidney co-transplanted with a vascularized thymic graft into non-human primates (NHPs). Although we have achieved pig-specific unresponsiveness in vitro, immunosuppression was not able to be fully weaned. Studies in mice and humanized mice suggest that a hybrid pig thymus (Hyb-thy)-containing host thymic epithelial cells (TECs) can optimize intra-thymic selection, achieving xenograft tolerance with improved reconstitution of T-cell function.
METHODS: We have tested the feasibility of the preparation of a Hyb-thy that contains NHP TECs in the donor thymic grafts. We first prepared the Hyb-thy in the donor pigs 2-3 weeks before xeno-Tx. We performed six cases of Hyb-thy preparation in six juvenile miniature swine. Two pigs received non-manipulated cynomolgus monkey thymic cells that were isolated from an excised atrophic thymus via injection into their thymic lobes (Group 1). The remaining four received thymic cells that were isolated from non-atrophic thymic glands (Groups 2 and 3). Pigs in Group 2 received unmanipulated thymic cells in one thymic lobe, as well as CD2-positive cell-depleted TEC-enriched cells in the contralateral lobe. Pigs in Group 3 received TEC-enriched cells alone.
RESULTS: All thymus-injected pigs received tacrolimus and rapamycin until endpoint (POD16). We detected cynomolgus monkey TEC networks in pig thymus from Groups 1 and 3, while pigs in Group 2 rejected the thymic cells. We demonstrated the preparation of Hyb-thy in pigs using tacrolimus plus rapamycin therapy.
CONCLUSIONS: Our results suggest that the enrichment of TEC from the excised NHP thymus facilitated NHP TEC engraftment in pig thymus.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  hybrid thymus; non-human primate; pig; vascularized thymus; xenotransplantation

Year:  2019        PMID: 31293016      PMCID: PMC6908759          DOI: 10.1111/xen.12543

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  55 in total

1.  Thymic transplantation in miniature swine. I. Development and function of the "thymokidney".

Authors:  K Yamada; A Shimizu; F L Ierino; R Utsugi; R N Barth; N Esnaola; R B Colvin; D H Sachs
Journal:  Transplantation       Date:  1999-12-15       Impact factor: 4.939

2.  The role of T cell help in the production of antibodies specific for Gal alpha 1-3Gal.

Authors:  Nathalie Cretin; Jennifer Bracy; Krista Hanson; John Iacomini
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

3.  High gradient magnetic cell separation with MACS.

Authors:  S Miltenyi; W Müller; W Weichel; A Radbruch
Journal:  Cytometry       Date:  1990

4.  Porcine CFSE mixed lymphocyte reaction and PKH-26 cell-mediated lympholysis assays.

Authors:  Manei Oku; Masayoshi Okumi; Hisashi Sahara; Atsushi Hirakata; Takashi Onoe; Adam D Griesemer; Kazuhiko Yamada
Journal:  Transpl Immunol       Date:  2008-08-15       Impact factor: 1.708

5.  Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model.

Authors:  Laura Higginbotham; Dave Mathews; Cynthia A Breeden; Mingqing Song; Alton Brad Farris; Christian P Larsen; Mandy L Ford; Andrew J Lutz; Matthew Tector; Kenneth A Newell; A Joseph Tector; Andrew B Adams
Journal:  Xenotransplantation       Date:  2015-04-03       Impact factor: 3.907

6.  Normal development in porcine thymus grafts and specific tolerance of human T cells to porcine donor MHC.

Authors:  B Nikolic; J P Gardner; D T Scadden; J S Arn; D H Sachs; M Sykes
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

7.  Induction of transplantation tolerance with a short course of tacrolimus (FK506): I. Rapid and stable tolerance to two-haplotype fully mhc-mismatched kidney allografts in miniature swine.

Authors:  R Utsugi; R N Barth; R S Lee; H Kitamura; J C LaMattina; J Ambroz; D H Sachs; K Yamada
Journal:  Transplantation       Date:  2001-05-27       Impact factor: 4.939

8.  Increased levels of anti-non-Gal IgG following pig-to-baboon bone marrow transplantation correlate with failure of engraftment.

Authors:  Fan Liang; Isaac Wamala; Joseph Scalea; Aseda Tena; Taylor Cormack; Shannon Pratts; Raimon Duran-Struuck; Nahel Elias; Martin Hertl; Christene A Huang; David H Sachs
Journal:  Xenotransplantation       Date:  2013-10-29       Impact factor: 3.907

9.  Despite efficient intrathymic negative selection of host-reactive T cells, autoimmune disease may develop in porcine thymus-grafted athymic mice: evidence for failure of regulatory mechanisms suppressing autoimmunity.

Authors:  Yong Zhao; Jose-Ignacio Rodriguez-Barbosa; Akira Shimizu; David H Sachs; Megan Sykes
Journal:  Transplantation       Date:  2003-06-15       Impact factor: 4.939

10.  Abnormal regulatory and effector T cell function predispose to autoimmunity following xenogeneic thymic transplantation.

Authors:  Yasuhiro Fudaba; Takashi Onoe; Meredith Chittenden; Akira Shimizu; Juanita M Shaffer; Roderick Bronson; Megan Sykes
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

View more
  2 in total

1.  Reduced positive selection of a human TCR in a swine thymus using a humanized mouse model for xenotolerance induction.

Authors:  Grace Nauman; Chiara Borsotti; Nichole Danzl; Mohsen Khosravi-Maharlooei; Hao-Wei Li; Estefania Chavez; Samantha Stone; Megan Sykes
Journal:  Xenotransplantation       Date:  2019-09-29       Impact factor: 3.907

Review 2.  Progress towards xenogenic tolerance.

Authors:  Erin M Duggan; Adam Griesemer
Journal:  Curr Opin Organ Transplant       Date:  2020-10       Impact factor: 2.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.